Latest

fingolimod

·November 7, 2022·5 min read

Changing Treatment Can Help Multiple Sclerosis Patients

The number of relapses in patients with relapsing-remitting multiple sclerosis was better controlled and symptoms of disability were stabilized or improved when patients who discontinued fingolimod changed to either ocrelizumab or natalizumab.

The image shows the top view of a mouse brain.

Featured Neurology Psychology

·May 28, 2014·3 min read

Drug Used to Treat MS May Have Beneficial Effects on Memory

Fingolimod, a drug widely used to treat multiple sclerosis, has been found to eliminate some adverse or traumatic memories, a new study reports.

Featured Neurology

·September 7, 2012·2 min read

Strategy Developed to Improve Delivery of Medicines to the Brain

The experimental treatment method allows small therapeutic agents to safely cross the blood-brain barrier in laboratory rats by turning off P-glycoprotein, one of the main gatekeepers preventing medicinal drugs from reaching their intended targets in the brain.